Back to News
Market Impact: 0.15
InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics
Source: PR Newswire
Healthcare & BiotechCompany Fundamentals
InMed Pharmaceuticals Inc. has changed its name to Mentari Therapeutics, Inc. The company said its shares are expected to begin trading on Nasdaq under ticker MTRI on November 9, 2026; the provided article text gives no further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- Fox completes its $22B acquisition of Roku
- Elanco Shares Jump After Q3 Beat and Outlook Raise
- Paraguay’s Santiago Pena under arrest, new president Pedro Alliana sworn in
- FIGS Beats Earnings as Demand Outstrips Supply, CEO Trina Spear Says
- OpenAI valued at $1.25 trillion, as rival Anthropic nears its IPO